- Stocks Telegraph
- Posts
- 11 Oct - Morning Newsletter (with changes)
11 Oct - Morning Newsletter (with changes)
4 Hot Stocks to Watch Today
Good Morning!
Stock markets in New York closed lower last Friday. The S&P 500 closed 0.19% lower at 4,391 points & the Nasdaq Composite ended down 0.51% at 14,579 points. Investors have thus had another fairly volatile week on the stock market, but the indices did manage to close the week higher. Friday's focus was on the disappointing jobs report.The labor department reported an increase of just 194,000 jobs, while the average expectation was 500,000. However, there were also bright spots, as unemployment fell to 4.8%, much lower than economists had forecast. Investors also toyed with the idea that a faltering labor market recovery could make the Federal Reserve decide to start phasing out the support program at a later date.Meanwhile, investors remain concerned about rising inflation and rising interest rates. US futures are down 0.40% for the Nasdaq on Monday morning. Stock market sentiment is also under pressure from soaring energy prices and fears that they could slow economic growth. The US oil price (WTI) is currently 1.7% higher at $80.70.
Make AAPL Pay 12x More With This...That's the power of using a simple trading strategy that 99% of investors miss. Free book reveals the step-by-step plan.So get it here now...
Today Top Movers
Adamas Pharmaceuticals Inc. (ADMS) stock soared 75.49% to $8.09 in the pre-market trading following the news that Supernus Pharmaceuticals will acquire Adamas Pharmaceuticals to strengthen its CNS product portfolio.
Trevi Therapeutics Inc. (NASDAQ: TRVI) shares are trading up 28.33% at $1.54 at the time of writing following the withdrawal of its original registration statement as per the SEC filing.
REGENXBIO Inc. (RGNX) share prices increasing 4.17% to $32.99 in premarket today after announcing initial data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular edema (CI-DME) using in-office suprachoroidal delivery.
Protagonist Therapeutics, Inc. (PTGX) is up 100.55% to $36.58 in early morning today after declaring that the U.S. Food and Drug Administration (FDA) has removed the full clinical hold on the Company's rusfertide clinical studies.
Had you put $2,000 into Microsoft at its IPO more than 30 years ago…you'd now have about $1.96 million. But one crypto investor turned his initial $8,500 stake into $7.5 million! Crypto is where it's at, and there's a simple way to start getting in on the action without having to be a crypto expert.
Top Upgrades & Downgrades
Raymond James turned bullish on ChemoCentryx Inc. (CCXI), upgrading the stock to Strong Buy and assigning a $107.00 price target, representing a potential upside of 178.57% from Friday's close.
Starbucks Corporation (SBUX) has won the favor of Deutsche Bank's equity research team. The firm upgraded the shares from Hold to Buy and moved their price target to $127.00.
3M Company (MMM) received an upgrade from analysts at Langenberg, who also set their one-year price target on the stock to $210.00. They changed their rating on MMM to Buy from Hold in a recently issued research note.
Earlier Monday Goldman Sachs reduced its rating on ConocoPhillips (COP) stock to Neutral from Buy and assigned the price target to $76.00.
Keybanc analysts reduced their investment ratings, saying in research reports covered by the media that its rating for FMC Corporation (FMC) has been changed to Sector Weight from Overweight.
Analysts at Piper Sandler downgraded Cloudflare Inc. (NET)'s stock to Neutral from Overweight Monday.
Next Big Tech Trend Will Put Well Known Businesses in Bankruptcy.Legend who bought Amazon at $48 says there's a huge new tech trend coming to your hometown - which could make you a small fortune over the next few years.And today he's revealing the name and stock ticker symbol of his favorite way to make money from this trend for FREE
Latest Insider Activity
Merus N.V. (MRUS) 10% Owner BVF PARTNERS L P/IL announced the sale of shares taking place on Oct 08 at $27.79 for some 147,267 shares. The total came to more than $4.09 million.
Aehr Test Systems (AEHR) Director SCOTT GEOFFREY GATES sold on Oct 07 a total 240,000 shares at $15.98 on average. The insider’s sale generated proceeds of almost $0.16 million.
ImmunityBio Inc. (IBRX) CEO & President Adcock Richard declared the purchase of shares taking place on Oct 08 at $8.81 for some 1,930 shares. The transaction amount was around $16995.0.
Analog Devices Inc. (ADI) Director EVANS BRUCE R bought on Oct 06 a total 100,358 shares at $164.98 on average. The purchase cost the insider an estimated $1.32 million.
Man Who Beat Buffett Says: "Inflation isn't temporary."He called Black Monday, the dot-com bubble and the financial crisis ahead of time. Now he has a disturbing inflation prediction.
Important Earnings
Top US earnings releases scheduled for tomorrow include Pinnacle Financial Partners Inc. (NASDAQ:PNFP). It will announce its Sep 2021 financial results. The company is expected to report earnings of $1.55 per share from revenues of $328.81M in the three-month period.
Analysts expect SMART Global Holdings Inc. (NASDAQ:SGH) to report a net income (adjusted) of $1.6 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Aug 2021 is predicted to come in at $461.3M.
VOXX International Corporation (VOXX), due to announce earnings after the market closes tomorrow, is expected to report earnings of $0.07 per share from revenues of $134.39M recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.